YUPING XIA

yx61175c@westpost.net * (617) 642-0952

PROFILE
Accomplished life scientist, physician with specialty of cancer registry. Commit
ted, experienced, and results-oriented professional with extensive experience th
e field of clinical research. Particular expertise in hematology and oncology. S
killed in the writing and presentation of complex technical information. Strong
research, analytical, interpersonal, communication skills, as well as the abilit
y to interact with ease across all levels of an organization. Published importan
t findings in hematology and oncology research as author and co-author in leadin
g journals such as Blood, Br J Haematol, Transfusion, and Proceeding of the Amer
ican Association for Cancer Research, and hematology/oncology research presentat
ion in ASH Meeting. Excellent project management skills and ability to manage co
mpeting priorities and maintain timeliness with all commitments.
EXPERIENCE
CLINPROXY Research Services
Clinical Research Associate, 2010-Present
Project: Double -blind, controlled Phase II study on efficacy of the lowering ef
fect of PROLIPOSTAT on blood concentrations of low-density lipoprotein cholester
ol (LDL-C) in patients with normal and elevated blood concentrations of LDL-C.
* Carried out Home-Based Clinical Research Associate tasks, independently and wi
thin teams
* Designed the Clinical Trial Protocol and Case Report Forms (CRFs).
* Managed assigned investigational study sites and performed onsite quality revi
ew of case report form data.
* Conducted routine monitoring visits to ensure investigator and staff were in c
ompliance with protocol, FDA, TPD and ICH/GCP guidelines and pertinent SOPs.
* Developed and implemented site initiation, routine monitoring, and closure che
cklists.
* Verified case report form information against source documents and reconcile d
ata entry queries, analysis.
* Reviewed site study files for completeness and up-to-date information, includi
ng IRB-related documents.
* Performed drug accountability and reconcile counts with CRF, source data, and
dispensing logs.
* Oversaw and evaluated subject enrollment and complied and reviewed patients' s
tatus tracking information.
* Ensured informed consent is administered properly and advise site of any execu
tion issues.
* MedDRA coding
* Checked for new adverse events and its reporting.
* Finalized and approved protocol, submitted request investigational drug suppli
es. Participated in development of informed consent forms.
AUREUS Radiology, LLC, Omaha, NE
Consultant, 2009-2010
* Worked at cancer care program/radiation department with Cooley Dickinson Hospi
tal, Northampton, MA.
* Responsible for cancer registry database review, re-abstracting, defining GenE
DITS checks, and reporting.
* Performed data management activities on the assigned projects in a timely and
efficient manner.
* Review and follow-up patient's diseases status, laboratory alerts, medical vio
lations, collection and review of outcomes, cancer survival research.
* Communicated medical resource issues to other facilities or State Cancer Regis
try.
* Designed and implemented the necessary forms for the collection processing and
 analysis of data.
* Assembled and disseminated data collected in the tumor registry databases; pre
sentation and answer requests for data, prepared routine and special reports tha
t summarize the cancer experience of the hospital.
Dana-Farber Cancer Institute / Partners Cancer Care (DFCI/PCC), Boston, MA
Certified Tumor Registrar, 2007-2009
* Involved in case identification, Abstraction and follow-up of cancer cases in
timely manner according to the Commission on Cancer/Facility Oncology Registry D
ata Standards; Cancer Committee activities.
* Reviewed and analyzed cases from the hospital medical records/electronic Healt
h Record Data for identifying cases that meet requirements and goals, and adhere
nce to protocol requirements.

YUPING XIA
yx61175c@westpost.net * (617) 642-0952
~ Page 2 ~
EXPERIENCE (CONT'D.)
Tufts University, Boston, MA
Sr. Research Associate, 2004-2005
* Conducted research on Promoter methylation silencing of the APRIN gene in brea
st, prostate, and ovarian cancers.
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Sr. Research Associate, 1995-2003
* Hematology/Oncology Unit, a key staff on drug candidate projects at both clini
cal and development stages.
* Assisted in the study design, initiations through close out and publications.
* Applied biomarkers and drug metabolism and Pharmacokinetics to improve clinica
l characterization of drug candidates.
o Thrombopoietin (TPO), phase II, with Amgen
o Eptifibatide (Integrilin), phase II, with COR Therapeutics, Inc.
o Evaluate the Efficacy and Safety of Infusible Platelet Membrane (IPM) in Throm
bocytopenic Patients with active Bleeding, Phase II, with PRP, Inc.
o Chemotherapy drugs induced thrombocytopenia with NIH grant
o Calcium triggering the apoptotic model of platelets in vitro
Nanjing Hospital, Southeast University, Medical College, Nanjing, China
Attending Physician/Clinical Fellow/Resident, 1983-1995
* Internal Medicine, in charge of inpatient and outpatient care with medical sta
ff of eight and residents.
* Diagnosis and treatment of acute and chronic hepatitis, hepatoma, and various
infectious diseases.
* Technique- liver biopsy and peritoneal jugular shunting to treat the refractor
y cirrhotic ascites.
* Clinical research of chronic active hepatitis.
CLINICAL TRAINING EXPERIENCE
Southside Hospital, North Shore-Long Island Jewish Health System, Long-Island, N
Y, 2006-2006
Family Medicine Rotation/ACGME accredited program in Family Medicine
* Internal Medicine/Emergency Room/ICU
Malden Medical Center/Asthma & Allergy Specialists, PC, Malden, MA, 2005-2006
Clinical Rotation
EDUCATION
Southeast University, Medical College, Nanjing, Jiangsu Province, China, 1978-19
83
Bachelor of Medicine
CERTIFICATES
Clinical Research Professional Development Program, Kriger Research Center, Inc.
June, 2010
Clinical Trial Monitoring and Research Site Coordination/ the International Conf
erence on Harmonization (ICH)/ and Good Clinical Practice (GCP) Guidelines
Cancer Registry Management Certificate Program, AHIMA, 2006-2008
Certified Tumor Registrar # 2008221, 2008
Certificate of Educational Commission for Foreign Medical Graduates, 2005
PROFESSIONAL ASSOCIATIONS
National Cancer Registry Association (NCRA)